title: Hyperprolactinaemia with amisulpride.
abstract: Psychopharmaca are used in treatment of psychiatric illnesses and disorders, among other therapeutic possibilities. The choice of the psychopharmaca is determined by the specific psychopathology of the patient, within the diagnostic categories, according to the current classification of diseases and disorders. With the advances in pharmaco industry, the range of drugs used in the everyday clinical practice is occurring at a very rapid pace. Antipsychotic medications are used in treatment of mainly psychotic disorders. However, the new generation of antipsychotics, due to their specific receptor affinities, is sometimes used in treatment of affective disorders as well. We are reporting a case of a female patient who was hospitalized several times. Amisulpride was introduced in the treatment and due to a series of unfortunate events and changes that followed (i. e. frequent hospitalizations and changes of therapists, different mental institutions) dose of amisulpride was gradually increased to its antipsychotic doses, which did not help achieve therapeutic benefits, but serious side effects.
authors: University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Rijeka, Croatia. ruzic.klementina@gmail.com
authors: Klementina
authors: K
authors: Ružić
authors: Tanja
authors: T
authors: Grahovac
authors: Mirjana
authors: M
authors: Graovac
authors: Elizabeta
authors: E
authors: Dadić-Hero
authors: Dubravka
authors: D
authors: Sepić-Grahovac
authors: Vladimir
authors: V
authors: Sabljić
mesh_terms: D000077582:Amisulpride; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D001883:Borderline Personality Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced / Q000175:diagnosis / Q000523:psychology; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D008875:Middle Aged; D010359:Patient Readmission; D013001:Somatoform Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D013469:Sulpiride; D000077582:Amisulpride